Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall XR vs Strattera in pediatric ADHD
NCT00506727Phase 4Completed
- Sponsor
- Takeda
- Start
- Aug 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of adderall xr in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Takeda. Primary endpoint: Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) Deportment Scale at 3 weeks. Started Aug 2003; status: completed.
02
Drugs
adderall xr
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00506727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506727.